Table 1. Characteristics of laboratories that reported MRSA and livestock-associated MRSA ST398 isolates from human samples, Europe, 2007*.

Laboratory no.	Country	Type of laboratory	Source of MRSA isolates	No. MRSA isolates received	No. MRSA isolates typed	MRSA ST398 isolates
						No. (%)	95% CI
1	Austria	National ref	All	523	523	0	0–0.7
2	Austria	National ref	All	586	586	16 (2.7)	1.7–4.4
3	Belgium	National ref	All	329	149	7 (4.7)	2.3–9.4
4	Czech Republic	National ref	Blood	37	10	0	0–27.8
5	Denmark	National ref	All	659	659	14 (2.1)	1.3–3.5
	Denmark	National ref	Clinical	370	370	6 (1.6)	0.7–3.5
6	Finland	National ref	All	1,323	1,323	1 (0.1)	0–0.4
7	Germany	National ref	Clinical	1,293	1,293	9 (0.7)	0.4–1.3
8	Germany	Regional ref	Clinical	866	866	37 (4.3)	3.1–5.8
9	Greece	National ref	Clinical	336	336	0	0–1.1
10	Hungary	National ref	All	365	63	0†	NA
11	Iceland	National ref	Clinical	21	21	0	0–15.5
12	Italy	National ref	Clinical	108	108	1 (0.9)	0.2–5.1
13	Ireland	National ref	Clinical	832	696	0	0–0.5
14	The Netherlands	National ref	Clinical	478	478	57 (11.9)	9.3–15.1
15	The Netherlands	Local	Clinical	12	12	3 (25.0)	8.9–53.2
16	Sweden	National ref	All	1,127	1,127	8 (0.7)	0.4–1.4
17	Switzerland	Local	Clinical	587	65	0†	NA
18	Switzerland	Regional ref	All	182	182	0	0–2.1
19	Switzerland	Regional ref	Clinical	64	64	0	0–5.7
20	Switzerland	Local	All	80	78	0	0–4.7
21	Turkey	Local	Clinical	198	60	0	0–6.0

*MRSA, methicillin-resistant Staphylococcus aureus; ST398, sequence type 398; CI, confidence interval; ref, reference laboratory; NA, not applicable.
†Not reported because laboratory typed <25% of MRSA isolates.